In patients with RAS/RAF mutant right-sided colon tumors, PFS was similar between those treated with anti-VEGF plus doublet therapy and anti-VEGF plus triplet therapy (16.7 vs. 11.2 months, p = 0.246) (Supplementary Figure S1). Here, VEGFA is linked to colonic neoplasm.